Refractive Error and Biometry in Retinopathy of Prematurity
NCT03334513
·
clinicaltrials.gov ↗
COMPLETED
Status
35
Enrollment
OTHER
Sponsor class
Conditions
Retinopathy of Prematurity
Interventions
DRUG:
Bevacizumab
DRUG:
Ranibizumab
Sponsor
San Ni Chen